# Fabino Enterprises Ltd (FABINO)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹20.31
Day Change: +0%
52W High: ₹38.96
52W Low: ₹13.1
Market Cap: ₹4 Cr

## Valuation
P/E: 0
P/B: 1.06
EPS: ₹-0.73
Book Value: ₹19.22
Dividend Yield: 0%

## Returns
1Y Return: -21.73%

## Profitability
ROE: 0%
ROCE: 0%
Debt/Equity: 0
Revenue Growth: 0%
Profit Growth: 0%
EBITDA Margin: 0%
Operating Margin: 0%

## About
Fabino Enterprises Ltd is a Drug Manufacturers - Specialty & Generic company listed on BSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Fabino Enterprises Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Draft Letter of Offer
- Announcement: Detailed Public Statement
- BSE Filing: Draft Letter of Offer

## Data Freshness
Quote Updated: 2026-05-17T02:08:19.675Z
Price History Updated: 2026-05-19T01:03:11.359Z
Latest Price History Date: 2026-05-15
Technicals Updated: 2026-05-19T01:03:11.359Z
Quant Updated: 2026-05-19T01:03:11.359Z
Sentiment Updated: 2026-05-19T01:03:11.359Z
Financials Status: current
Financials Updated: 2026-05-18T16:30:02.025Z
Financials Last Attempt: 2026-05-18T16:30:02.025Z
Financials Provider Tried: database
Latest P&L Period: FY 2025
Latest Balance Sheet Period: FY 2025
Latest Cash Flow Period: FY 2025

## P&L (Mar 2024)
Revenue: ₹3.36 Cr
Operating Profit: ₹0.03 Cr (OPM 0.89%)
Net Profit: ₹0.01 Cr
Tax: ₹0.01 Cr

## Annual P&L History
Mar 2024: Rev ₹3.36Cr | PAT ₹0.01Cr | OPM 0.89%
Mar 2025: Rev ₹21.01Cr | PAT ₹0.04Cr | OPM 0.57%
TTM: Rev ₹17.98Cr | PAT ₹0.06Cr | OPM 0.61%

## Balance Sheet (Mar 2024)
Total Assets: ₹5.02 Cr
Total Liabilities: ₹5.02 Cr
Borrowings: ₹0.41 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

---
Source: rupiya.io/stocks/fabino
Disclaimer: For research and education only. Not investment advice.